Loading dose versus standard regime of magnesium sulfate in the management of eclampsia: a randomized trial
- PMID: 12214831
- DOI: 10.1046/j.1341-8076.2002.00029.x
Loading dose versus standard regime of magnesium sulfate in the management of eclampsia: a randomized trial
Abstract
Objective: To determine whether only loading dose of magnesium sulfate is effective in controlling convulsion in eclampsia.
Study methods: This prospective study was conducted in Dhaka Medical College and Hospital, Bangladesh between July and November 1999. Eclamptic patients who were eligible for magnesium sulfate (MgSO4) therapy were randomly assigned by lottery to receive either only loading dose (n = 202) or standard regime (n = 199) of MgSO4. Besides the anticonvulsant, patients of both the groups were managed by same protocol for eclampsia management prepared by Eclampsia Working Group, Bangladesh. Efficacy of both the regimes was assessed by measuring the rate of recurrent convulsion. Results were expressed as mean +/- SD and a proportion. Statistical analysis was done using unpaired t-test, Z-test and chi2 test as appropriate. A P-value of < 0.05 was considered significant.
Results: At the time of randomization there were no significant differences between the two groups in terms of age (22.40 +/- 4.21 vs 22.49 +/- 4.67 years), parity (72.77% vs 70.35% primi), type of eclampsia (84.65% vs 85.42% antepartum eclampsia), number of convulsions (5.30 +/- 3.26 vs 5.48 +/- 3.32 times), gestational age (35.65 +/- 3.37 vs 35.13 +/- 3.26 weeks), systolic blood pressure (153.19 +/- 20.19 vs 154.17 +/- 22.32 mmHg), diastolic blood pressure (106.23 +/- 13.84 vs 105.60 +/- 12.88 mmHg), proteinuria (70.80% vs 72.36% had > + proteinuria) and Glasgow Coma Scale (GCS) (73.26% vs 75.88% > 8) for the loading and standard regime groups. There were also no differences between the two groups in mean fit and treatment interval (6.88 +/- 5.26 vs 7.12 +/- 4.29h), fit and delivery interval (11.35 +/- 10.22 vs 11 +/- 6.69h) and return of consciousness (10.94 +/- 8.29 vs 11.24 +/- 8.37h). The recurrent convulsion rate was almost the same in both the groups (3.96% in loading vs 3.51% in standard regime, P > 0.05). Case fatality rate was 4.45% and 5.02% in loading and standard regime groups, respectively (P > 0.05).
Conclusion: Only loading dose of MgSO4 can control convulsion in eclampsia and it is as effective as standard regime.
Similar articles
-
A low dose ("Dhaka") magnesium sulphate regime for eclampsia.Acta Obstet Gynecol Scand. 2001 Nov;80(11):998-1002. Acta Obstet Gynecol Scand. 2001. PMID: 11703195 Clinical Trial.
-
Maternal outcomes after 12hours and 24hours of magnesium sulfate therapy for eclampsia.Int J Gynaecol Obstet. 2016 Jan;132(1):68-71. doi: 10.1016/j.ijgo.2015.06.056. Epub 2015 Oct 14. Int J Gynaecol Obstet. 2016. PMID: 26604159 Clinical Trial.
-
Loading dose of magnesium sulphate versus standard regime for prophylaxis of pre-eclampsia.J Coll Physicians Surg Pak. 2009 Jan;19(1):30-3. J Coll Physicians Surg Pak. 2009. PMID: 19149977 Clinical Trial.
-
Magnesium sulfate is the ideal anticonvulsant in preeclampsia-eclampsia.Am J Obstet Gynecol. 1990 May;162(5):1141-5. doi: 10.1016/0002-9378(90)90002-o. Am J Obstet Gynecol. 1990. PMID: 2288560 Review.
-
Clinical pharmacokinetic properties of magnesium sulphate in women with pre-eclampsia and eclampsia.BJOG. 2016 Feb;123(3):356-66. doi: 10.1111/1471-0528.13753. Epub 2015 Nov 24. BJOG. 2016. PMID: 26599617 Free PMC article. Review.
Cited by
-
Magnesium sulphate therapy in eclampsia: the Sokoto (ultra short) regimen.BMC Res Notes. 2009 Aug 19;2:165. doi: 10.1186/1756-0500-2-165. BMC Res Notes. 2009. PMID: 19691837 Free PMC article.
-
Alternative magnesium sulphate regimens for women with pre-eclampsia and eclampsia.Cochrane Database Syst Rev. 2010 Aug 4;2010(8):CD007388. doi: 10.1002/14651858.CD007388.pub2. Cochrane Database Syst Rev. 2010. Update in: Cochrane Database Syst Rev. 2023 Oct 10;10:CD007388. doi: 10.1002/14651858.CD007388.pub3. PMID: 20687086 Free PMC article. Updated.
-
Antenatal magnesium sulphate and adverse neonatal outcomes: A systematic review and meta-analysis.PLoS Med. 2019 Dec 6;16(12):e1002988. doi: 10.1371/journal.pmed.1002988. eCollection 2019 Dec. PLoS Med. 2019. PMID: 31809499 Free PMC article.
-
Risk factors for maternal mortality associated with eclampsia presenting at a Nigerian tertiary hospital.Int J Womens Health. 2018 Nov 6;10:715-721. doi: 10.2147/IJWH.S178729. eCollection 2018. Int J Womens Health. 2018. PMID: 30464647 Free PMC article.
-
Open-labelled randomised controlled trial of 12 hours versus 24 hours modified Pritchard regimen in the management of eclampsia and pre-eclampsia in Ghana (MOPEP Study): study protocol.BMJ Open. 2019 Oct 22;9(10):e032799. doi: 10.1136/bmjopen-2019-032799. BMJ Open. 2019. PMID: 31641005 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources